BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12099050)

  • 21. [Structural proteomics and patents].
    Sumikura K
    Tanpakushitsu Kakusan Koso; 2002 Jun; 47(8 Suppl):967-72. PubMed ID: 12099048
    [No Abstract]   [Full Text] [Related]  

  • 22. Protein-protein docking in CAPRI using ATTRACT to account for global and local flexibility.
    May A; Zacharias M
    Proteins; 2007 Dec; 69(4):774-80. PubMed ID: 17803217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biophysical techniques for ligand screening and drug design.
    Renaud JP; Delsuc MA
    Curr Opin Pharmacol; 2009 Oct; 9(5):622-8. PubMed ID: 19581126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative proteomics for drug toxicity.
    Gao Y; Holland RD; Yu LR
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docking without docking: ISEARCH--prediction of interactions using known interfaces.
    Günther S; May P; Hoppe A; Frömmel C; Preissner R
    Proteins; 2007 Dec; 69(4):839-44. PubMed ID: 17803236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From the Mediterranean coast to the shores of Lake Ontario: CAPRI's premiere on the American continent.
    Wodak SJ
    Proteins; 2007 Dec; 69(4):697-8. PubMed ID: 17912754
    [No Abstract]   [Full Text] [Related]  

  • 27. A computational approach for ordering signal transduction pathway components from genomics and proteomics Data.
    Liu Y; Zhao H
    BMC Bioinformatics; 2004 Oct; 5():158. PubMed ID: 15504238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel approach to local similarity of protein binding sites substantially improves computational drug design results.
    Ramensky V; Sobol A; Zaitseva N; Rubinov A; Zosimov V
    Proteins; 2007 Nov; 69(2):349-57. PubMed ID: 17623865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomics and proteomics in process development: opportunities and challenges.
    Gupta P; Lee KH
    Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional annotation by sequence-weighted structure alignments: statistical analysis and case studies from the Protein 3000 structural genomics project in Japan.
    Standley DM; Toh H; Nakamura H
    Proteins; 2008 Sep; 72(4):1333-51. PubMed ID: 18384072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ProGenGrid: a grid-enabled platform for bioinformatics.
    Aloisio G; Cafaro M; Fiore S; Mirto M
    Stud Health Technol Inform; 2005; 112():113-26. PubMed ID: 15923721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying task analysis to describe and facilitate bioinformatics tasks.
    Tran D; Dubay C; Gorman P; Hersh W
    Stud Health Technol Inform; 2004; 107(Pt 2):818-22. PubMed ID: 15360926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating protein structures determined by structural genomics consortia.
    Bhattacharya A; Tejero R; Montelione GT
    Proteins; 2007 Mar; 66(4):778-95. PubMed ID: 17186527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From bioarrays to diagnostics: a systemomics approach.
    Appasani K
    Expert Rev Mol Diagn; 2004 Jan; 4(1):1-5. PubMed ID: 14711343
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell biology, chemogenomics and chemoproteomics.
    Gagna CE; Winokur D; Clark Lambert W
    Cell Biol Int; 2004; 28(11):755-64. PubMed ID: 15563397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biomarkers in drug development.
    Lewin DA; Weiner MP
    Drug Discov Today; 2004 Nov; 9(22):976-83. PubMed ID: 15539141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
    Kirton SB; Murray CW; Verdonk ML; Taylor RD
    Proteins; 2005 Mar; 58(4):836-44. PubMed ID: 15651036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein structure similarity clustering (PSSC) and natural product structure as inspiration sources for drug development and chemical genomics.
    Dekker FJ; Koch MA; Waldmann H
    Curr Opin Chem Biol; 2005 Jun; 9(3):232-9. PubMed ID: 15939324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Crystallography-based drug design].
    Matsuzaki T
    Tanpakushitsu Kakusan Koso; 2005 Jun; 50(7):869-75. PubMed ID: 15957411
    [No Abstract]   [Full Text] [Related]  

  • 40. Application of genomics in bacterial vaccine discovery: a decade in review.
    Zagursky RJ; Anderson AS
    Curr Opin Pharmacol; 2008 Oct; 8(5):632-8. PubMed ID: 18625342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.